PORTLAND, Maine — The Bristol-Myers Squibb Foundation has awarded a $5 million grant to Maine Medical Center (MMC) for the creation of a statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine, where incidence rates and deaths due to lung cancer are among the highest in the nation, according to the Centers for Disease Control and Prevention.
The Maine Lung Cancer Prevention and Screening (Maine LungCAPS) Initiative is a four-year multi-institution, multi-disciplinary collaboration of Maine health care providers and stakeholders.
$5.6 million grant award to create state-wide prevention and screening program
There is a harsh reality facing the people of Maine: local lung cancer rates are among the highest in the nation and the leading cause of cancer deaths in the state. For years, an ad-hoc network of isolated programs have struggled to make improvements, but one Maine physician is ready to take on the entire spectrum of cancer screening, prevention and treatment in a bid save move lives.
Paul Han, MD, MA, MPH, director of the Center for Outcomes Research and Evaluation at the MMC Research Institute, is the Principal Investigator for the recently announced Maine LungCAPS initiative, a program designed to improve the prevention, early detection and treatment of lung cancer in Maine.
MCF: What drew you toward a career in medicine?
The Portland City Council gave unanimous approval on Monday night to a new proposal by the Health and Human Services Committee that will raise the minimum age for the purchase of tobacco products from 18 to 21 years of age.
"We applaud this move by the Portland City Council," said Tara Hill, Executive Director of Maine Cancer Foundation. "Maine has one of the highest rates of lung cancer death in the country, and tobacco use accounts for nearly half of all cancer deaths in our state. We share a deep commitment to reducing tobacco use in our state, especially among young people."